Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr Sarah Dorval from Villers-le-Bouillet, company number BE0763321011, closed financial year 2025 with a result of € 36,952 after tax. For that financial year Dr Sarah Dorval recorded a gross margin of € 51,222 and equity of € 3,300. Compared with financial year 2024, the result moved from € 54,594 to € 36,952. The company is profitable. The buffer shrank hard: equity is 96 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.
€ 3,300
▼ 96% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 36,952
▼ 32% vs 2024
Profit after tax over the fiscal year.
€ 45,221
▼ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 119,430 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,107
▼ 67% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,215
▼ 12% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 7,234 | € 34,509 | € 72,479 | € 51,222 | ▼ 29% |
| Profit after taxes | € 4,743 | € 22,675 | € 54,594 | € 36,952 | ▼ 32% |
| Equity | € 8,509 | € 31,184 | € 85,779 | € 3,300 | ▼ 96% |
| Total debts | € 51,801 | € 38,394 | € 22,799 | € 74,759 | ▲ 228% |
| Cash | € 49,130 | € 69,309 | € 80,913 | € 45,221 | ▼ 44% |
| Retained profit | € 5,509 | € 28,184 | € 82,779 | € 300 | ▼ € 82,479 |
| Dividend | € 0 | € 0 | € 0 | € 119,430 | |
| Balance sheet total | € 60,310 | € 69,578 | € 108,578 | € 78,059 | ▼ 28% |
Key figures of Dr Sarah Dorval, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr Sarah Dorval?
What happened at Dr Sarah Dorval in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 36,952 (▼ 32% vs 2024). Source: NBB ↗
- New establishment in Lasne. KBO
- Sarah Dorval became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 4,743 profit in 2022 to € 36,952 profit in 2025.
Paid € 36,469 in corporate taxes since 2022.
Best year ever: 2024, with € 54,594 profit.
Paid out € 119,430 in dividends to the owners in total.
Management
Behind Dr Sarah Dorval is Sarah Dorval.
Directors
According to the 2025 annual accounts
Sarah Dorval
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Rue Magritte 8
4530 Villers-le-Bouillet
Chemin des Ornois 10
1380 Lasne
Active since 7 February 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0763.321.011
- VAT number
- BE 0763.321.011
- Registered office
- Rue Magritte 8, 4530 Villers-le-Bouillet
- Names & denominations
- Dr Sarah Dorval
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 February 2021
- Peppol
- Active · Active since 18 Dec 2025